This isn’t Eliaz Therapeutics’s most recent raise. Reg CF Offering (2026) (Open) is more current.View latest round

Rule 506(c) Private Offering (2026)

ClosedReg DPreferred Equity

Reported to the SEC on Form D · last checked Sep 23, 2026

Raised

$55K

Investors

—

Estimated pre-money

$48.5M

—

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Deal terms

Est. pre-money$48.5M

Price / share$5.5596

Estimated, not stated: $5.5596 × 8,719,263 securities outstanding as of Apr 29, 2026 (Form C-AR filed Apr 29, 2026, p. 17).

Offering details

Target—

Max—

Min investment—

OpenedApr 15, 2026

Deadline—

ClosedApr 15, 2026

Days active1

Links & provenance

SEC filing

Source: SEC EDGAR
Last synced Sep 23, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.